NCT00006495View on ClinicalTrials.gov

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 2004

Conditions
HIV Infections
Interventions
BIOLOGICAL

ALVAC(2)120(B,MN)GNP (vCP1452)

BIOLOGICAL

HIV-1 Immunogen

Trial Locations (9)

14642

Univ. of Rochester ACTG CRS, Rochester

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

21287

Johns Hopkins Adult AIDS CRS, Baltimore

90095

UCLA CARE Center CRS, Los Angeles

275997215

Unc Aids Crs, Chapel Hill

331361013

Univ. of Miami AIDS CRS, Miami

775550435

Univ. of Texas Medical Branch, ACTU, Galveston

02114

Massachusetts General Hospital ACTG CRS, Boston

02215

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH